Analyst Activity – HC Wainwright Reiterates Buy on Insmed (NASDAQ:INSM)

ME Staff
-
0

Analyst Ratings For Insmed (NASDAQ:INSM)

Today, HC Wainwright reiterated its Buy rating on Insmed (NASDAQ:INSM).

There are 1 hold rating, 4 buy ratings on the stock.

The current consensus rating on Insmed (NASDAQ:INSM) is Buy (Score: 2.80) with a consensus target price of $22.75 per share, a potential 44.35% upside.

Some recent analyst ratings include

  • 8/2/2017-HC Wainwright Reiterated Rating of Buy.
  • 7/10/2017-Robert W. Baird initiated coverage with a Outperform rating.
  • 6/11/2017-Citigroup Inc. Reiterated Rating of Neutral.
  • 4/17/2016-Cowen and Company Reiterated Rating of Buy.

Recent Insider Trading Activity For Insmed (NASDAQ:INSM)
Insmed (NASDAQ:INSM) has insider ownership of 5.10% and institutional ownership of 91.91%.

  • On 5/31/2017 Christine A Pellizzari, General Counsel, bought 10,000 with an average share price of $15.14 per share and the total transaction amounting to $151,400.00. View SEC Filing
  • On 12/15/2016 Christine A Pellizzari, General Counsel, bought 20,000 with an average share price of $12.81 per share and the total transaction amounting to $256,200.00. View SEC Filing
  • On 12/14/2016 Myrtle S Potter, Director, sold 6,466 with an average share price of $12.79 per share and the total transaction amounting to $82,700.14. View SEC Filing
  • On 11/14/2016 Andrew T Drechsler, CFO, sold 45,000 with an average share price of $14.67 per share and the total transaction amounting to $660,150.00. View SEC Filing
  • On 11/9/2016 Orlov S Nicole Schaeffer, SVP, sold 68,774 with an average share price of $11.95 per share and the total transaction amounting to $821,849.30. View SEC Filing
  • On 2/1/2016 William Lewis, CEO, bought 50,000 with an average share price of $13.34 per share and the total transaction amounting to $667,000.00. View SEC Filing
  • On 9/2/2015 Donald J. Hayden, Jr., Director, sold 25,000 with an average share price of $24.06 per share and the total transaction amounting to $601,500.00. View SEC Filing

Recent Trading Activity for Insmed (NASDAQ:INSM)
Shares of Insmed closed the previous trading session at 15.76 down -0.41 -2.54% with 359,681 shares trading hands.